Cannell & Co’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
Cannell & Co's AGN Position: Q1 2019 in Review
Cannell & Co sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 16,125 shares — an estimated $2.15M sold.
Cannell & Co first reported a position in AGN in Q3 2014 and held it in 18 quarters. The position peaked at $84.3M in Q2 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.
- Cannell & Co reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
- Cannell & Co sold 16,125 Allergan plc shares in Q1 2019, an estimated $2.15M.
- Cannell & Co first reported a position in Allergan plc in Q3 2014 and held it in 18 quarters.
- Cannell & Co's Allergan plc position peaked at $84.3M in Q2 2015.
- 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.
Based on Cannell & Co's 13F filing for Q1 2019, filed 14 May 2019.